Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
BOSTON (Reuters) - Routine breast screening with mammograms is less effective at preventing cancer deaths than expected, Norwegian researchers said on Wednesday in a study that reignites a fierce debate over the value of screening.
LONDON (Reuters) - Scientists have found a region of DNA that can increase or decrease the high chance of breast cancer linked to a particular gene variant - a finding that could help doctors keep a closer eye on women most at risk.
CHICAGO (Reuters) - Atomic bomb blast victims lucky enough to survive one cancer have a high risk of developing a second, U.S. researchers said on Wednesday, in a study that offers new insights about cancer risks from radiation exposure.
Taking aspirin regularly may decrease risk of death from breast cancer and risk of breast cancer metastasis for women who have had early-stage breast cancer, an analysis indicates.
Three weeks of higher dose radiation worked as well as the standard-dose, five-week schedule after a lumpectomy for invasive, lymph node-negative disease, study shows.
New standards for ER, PR tests in breast cancer have been released by American Society of Clinical Oncology and College of American Pathologists.
Herceptin-based treatments without anthracyclines caused fewer cases of heart failure than treatments containing anthracyclines, study at San Antonio Symposium shows.
Increased access to treatment and follow-up care, protection of coverage in case of job change or loss, ensuring coverage despite pre-existing conditions and increasing quality and quantity of life for young women are among the ways the healthcare overhaul bill may impact people with a history of breast cancer.
A body mass index of more than 25 (being overweight or obese) is related to metastatic recurrence and poorer survival rates in women who have had breast cancer, according to results released at the San Antonio Breast Cancer Symposium.
Lapatinib plus Trastuzumab was more effective than Lapatinib alone for women with HER2 positive advanced breast cancer that progressed on trastuzumab, San Antonio study shows.